The Latest Breaking News from FDA

Häagen-Dazs ice cream products worth 12 million baht were destroyed at an industrial facility in Samut Prakan on Monday although their samples were not found to be contaminated with traces of a chemical linked to a cancer.

ORLANDO, Fla. — The Food and Drug Administration on Monday responded to the results of Florida Surgeon General Joseph Ladapo’s analysis of COVID-19 data that he says point to a risk for some men who get the shot.

U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 30 points on Monday.

U.S. stocks pared gains midway through trading, with the Dow Jones dropping more than 100 points on Monday.

Government initiatives to expand domestic biotech production and research and rising private investments in advancing technologies are expected to boost the industry’s prospects. While we believe biotech stocks Vertex Pharmaceuticals (VRTX) and Biogen (BIIB) could be ideal investments for the long run, fundamentally weak Timber Pharmaceuticals (TMBR) might be best…

The CDC is still citing underage consumption as a reason to restrict adult access.

The president's mass pardon does not extend to pot suppliers, and his rescheduling plans won't make marijuana a legal medicine.

The latest government study on teen vaping suggests there’s been little progress in keeping e-cigarettes out of the hands of kids

The FDA's nicotine restrictions will push consumers toward black-market suppliers, who are completely unconstrained by the FDA’s regulations.

Gainers Chardan NexTech Acquisition 2 Corp. (NASDAQ: CNTQ) shares surged 102.6% to close at $21.54 on Wednesday.

LOS ANGELES -- Patients arriving at Dr. Philip O'Carroll's Newport Beach office for their first ketamine treatment are in pain and often lost. They have visited other doctors, tried other solutions and are ready for what is considered a last resort.